US 7465831
Levalbuterol hydrochloride Polymorph A
granted A61PA61P11/00A61P11/06
Quick answer
US patent 7465831 (Levalbuterol hydrochloride Polymorph A) held by Teva Pharmaceutical Fine Chemicals S.R.L. expires Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Pharmaceutical Fine Chemicals S.R.L.
- Grant date
- Tue Dec 16 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 11 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P11/00, A61P11/06, A61P11/08, A61P43/00